Biolegend, 805602, Purified anti-β-Amyloid, 1-43 Antibody (Previously Covance catalog# SIG-39143), 500microl

Amyloid beta (Aβ or Amyloid beta) denotes peptides of 36-43 amino acids in length that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients. The peptides result from the amyloid precursor protein (APP), which is cut by certain enzymes to yield Aβ. Aβ molecules can aggregate to form oligomers (known as "seeds") which are believed to be able to induce other Aβ molecules to also take the misfolded oligomeric form, leading to a chain reaction akin to a prion infection. The seeds or the resulting amyloid plaques are toxic to nerve cells. The other protein implicated in Alzheimer's disease, tau protein, also forms such prion-like misfolded oligomers, and there is some evidence that misfolded Aβ can induce tau to misfold.
500microl
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution (no preservatives or carrier proteins).
Preparation: The antibody was purified by affinity chromatography.
Concentration: 0.5 mg/ml
Storage & Handling: This antibody should be handled aseptically as it is free of preservatives such as Sodium Azide. Store this antibody undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check the vial label or CoA to find the proper storage conditions.
Application: IHC-P - Quality tested WB - Reported in the literature, not verified in house
Recommended Usage: Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 1.0 - 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.
Application Notes: This antibody is reactive to the C-terminus of beta amyloid and is specific for the isoform ending at the 43rd amino acid. Additional reported applications (for the relevant formats) include: Western blotting (WB)
Application References(PubMed link indicates BioLegend citation): Takami M, et al. 2009. J. Neurosci. 41:13042. (WB) PubMed
Product Citations: Tan Z 2022. Acta Neuropathologica Communications. 10(1):182. PubMed Willumsen N, et al. 2023. Brain Commun. 5:fcac321. PubMed Takami M, et al. 2009. J Neurosci. 29:13042-13052. PubMed
RRID: AB_2750038 (BioLegend Cat. No. 805607) AB_2564686 (BioLegend Cat. No. 805601)
Cell Type: Embryonic Stem Cells
Biology Area: Cell Biology, Neurodegeneration, Neuroscience, Protein Misfolding and Aggregation, Stem Cells
Molecular Family: APP/β-Amyloid
Gene ID: 351
UniProt: View information about beta-Amyloid 1-43 on UniProt.org
Clone: 9C4/Amyloid
Regulatory Status: RUO
Other Names: AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2, Amyloid beta A4 protein, preA4, protease nexin-II, peptidase nexin-II, beta-amyloid peptide, alzheimer disease amyloid protein, cerebral vascular amyloid peptide, APP, Amyloid Precursor Protein
Previously: Signet Catalog# 9143-02Signet Catalog# 9143-05Signet Catalog# 9143-10Covance Catalog# SIG-39143
Isotype: Mouse IgG1